Impaired endothelial release of tissue-type plasminogen activator in patients with chronic kidney disease and hypertension.
about
Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expressionDependence of Proximal GC Boxes and Binding Transcription Factors in the Regulation of Basal and Valproic Acid-Induced Expression of t-PAIdentification of rat lung--prominent genes by a parallel DNA microarray hybridizationHistone deacetylase inhibitor treatment increases coronary t-PA release in a porcine ischemia model.Profibrinolytic effect of the epigenetic modifier valproic acid in man.The endothelium: influencing vascular smooth muscle in many ways.Pulmonary embolism in patients with CKD and ESRDOverwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients.The emerging role of coagulation proteases in kidney disease.Management of Atrial Fibrillation in Patients With Kidney Disease.The role of cGMP and its signaling pathways in kidney disease.Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin.Acute pulmonary thromboembolism occurring during treatment with tolvaptan in a patient with autosomal-dominant polycystic kidney disease.Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease.The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure lowering.Nebivolol, But Not Metoprolol, Treatment Improves Endothelial Fibrinolytic Capacity in Adults With Elevated Blood Pressure.Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse.Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up.Functional investigation of a venous thromboembolism GWAS signal in a promoter region of coagulation factor XI gene
P2860
Q28480965-8C5B5A5E-CA72-427F-93AF-4057BD155850Q28603981-183C413C-C7E4-469B-87C5-E562F669EB1DQ33236283-C3E01B25-8565-415A-B823-3055C5CD96FDQ33599573-46AB4196-09FD-4A19-A234-2B25D4C5D7A4Q34306821-74DFDA93-C532-4EF2-BFC0-B0F3E9038047Q34638538-3A454E34-5D14-4159-9732-2EC28632D756Q36294323-90BD8F0D-3084-4016-B8EA-BC4F600D06F5Q36396010-DDAD54A5-938E-4FA4-B07A-D108CEB1C9F0Q37066587-61EF644F-E428-47F2-BA43-4FC641DC70AAQ37469045-29432CA6-42EF-4F5D-957B-B33A0F6B0293Q38896087-CEA3443B-86E1-4112-8788-4048BB4FBCE9Q39864511-6C1CDC0B-A636-4ED2-845A-04D2041FCDC8Q41855559-9B77276D-EA9B-4969-9A94-3333389F36C5Q43545029-9ED3E4DB-B4DA-42CF-942D-4A8C3B042FAFQ43634793-DDFC0C45-A217-47CD-8C64-FA530FC70B3AQ47120708-FB3704A4-8DD4-4409-8688-1A33A59C57BEQ48487114-2EFCD476-7B24-49F0-A6A5-547EC899ACAFQ53193253-7F1A9EC2-73E3-404C-9FE8-4EEF741DFD7AQ59293937-1E36B9C9-D8B6-42BB-B728-48C6E4566A29
P2860
Impaired endothelial release of tissue-type plasminogen activator in patients with chronic kidney disease and hypertension.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Impaired endothelial release o ...... dney disease and hypertension.
@en
Impaired endothelial release o ...... dney disease and hypertension.
@nl
type
label
Impaired endothelial release o ...... dney disease and hypertension.
@en
Impaired endothelial release o ...... dney disease and hypertension.
@nl
prefLabel
Impaired endothelial release o ...... dney disease and hypertension.
@en
Impaired endothelial release o ...... dney disease and hypertension.
@nl
P2093
P1433
P1476
Impaired endothelial release o ...... dney disease and hypertension.
@en
P2093
Ola Samuelsson
Pia Ottosson
Sverker Jern
Thorarinn Gudnason
Thórdís Hrafnkelsdóttir
P304
P356
10.1161/01.HYP.0000137380.91476.FB
P407
P577
2004-07-12T00:00:00Z